Incorporating patient preferences into drug development and regulatory decision making: Results from a quantitative pilot study with cancer patients, carers, and regulators.
Clin Pharmacol Ther
; 99(5): 548-54, 2016 May.
Article
in En
| MEDLINE
| ID: mdl-26715217
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Design
/
Decision Making
/
Drug and Narcotic Control
/
Patient Preference
/
Neoplasms
Type of study:
Prognostic_studies
/
Qualitative_research
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Clin Pharmacol Ther
Year:
2016
Document type:
Article
Affiliation country:
Reino Unido